Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Another look at the data

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Nov 06, 2022 11:13am

447 Views

Post# 35077226

RE:RE:RE:RE:RE:Another look at the data

So so close we will see this SP adjust accordingly,already believe FDA has taken into account those 12 under optimized patients. And are just waiting for the next patient results to grant us BTD then AA, then off to the races

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?